September 2022 FDA Recall Drug by Remedyrepack Inc.
D-1538-2022 - Presence of Foreign Substance
This Class II drug recall was voluntarily initiated by Remedyrepack Inc. on September 15, 2022 for the product Drug. The FDA reported the reason for recall as presence of foreign substance. The product was distributed in Distributed to two direct accounts in PA and AK. and the recall is currently terminated.
Recall Number: D-1538-2022
Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.
09-15-2022
09-21-2022
1,699 blister cards/30 tablets each
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
RemedyRepack Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Distributed to two direct accounts in PA and AK.
11-16-2022
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Lisinopril 10 mg tablets, 30-count Blister Card, Rx Only, MFG: Lupin Pharma, Baltimore, MD Repackaged by: RemedyRepack Inc, Indiana PA. Original NDC# 68180-0980-03, Repackaged NDC# 70518-0468-00
Batch or Lot Expiration Information
Lot# J0636336-073022, J0637605-080422, Exp. date 08/31/2023